Clinical Trial Update: A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BR1400-1 through BR1400-5 in essential hypertension; the study has not yet begun recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BR1400-1
• BR1400-2
• BR1400-3
• BR1400-4
• BR1400-5

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 2 | Status: NOT_YET_RECRUITING